Filgrastim
Filgrastim is an active ingredient in 24 FDA-listed drug products sold under 7 names.
Drugs containing Filgrastim
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 69448-009 | Filkri Injection, Solution | 480 ug/.8mL | Accord BioPharma Inc., |
| 69448-008 | Filkri Injection, Solution | 300 ug/.5mL | Accord BioPharma Inc., |
| 63459-912 | Granix Injection, Solution | 480 ug/.8mL | Cephalon, LLC |
| 63459-910 | Granix Injection, Solution | 300 ug/.5mL | Cephalon, LLC |
| 63459-920 | Granix Injection, Solution | 480 ug/1.6mL | Cephalon, LLC |
| 63459-918 | Granix Injection, Solution | 300 ug/mL | Cephalon, LLC |
| 55513-546 | Neupogen Injection, Solution | 480 ug/1.6mL | Amgen, Inc |
| 55513-530 | Neupogen Injection, Solution | 300 ug/mL | Amgen, Inc |
| 55513-209 | Neupogen Injection, Solution | 480 ug/.8mL | Amgen, Inc |
| 55513-924 | Neupogen Injection, Solution | 300 ug/.5mL | Amgen, Inc |
| 0069-0291 | Nivestym Injection, Solution | 300 ug/.5mL | Pfizer Laboratories Div Pfizer Inc |
| 0069-0292 | Nivestym Injection, Solution | 480 ug/.8mL | Pfizer Laboratories Div Pfizer Inc |
| 0069-0293 | Nivestym Injection, Solution | 300 ug/mL | Pfizer Laboratories Div Pfizer Inc |
| 0069-0294 | Nivestym Injection, Solution | 480 ug/1.6mL | Pfizer Laboratories Div Pfizer Inc |
| 69097-430 | Nypozi Injection | 300 ug/300ug | Cipla USA Inc. |
| 69097-429 | Nypozi Injection | 480 ug/480ug | Cipla USA Inc. |
| 72374-101 | NYPOZI txid Injection | 300 ug/300ug | Tanvex BioPharma USA, Inc. |
| 72374-102 | NYPOZI txid Injection | 480 ug/480ug | Tanvex BioPharma USA, Inc. |
| 70121-1571 | Releuko Injection, Solution | 480 ug/1.6mL | Amneal Pharmaceuticals LLC |
| 70121-1570 | Releuko Injection, Solution | 480 ug/.8mL | Amneal Pharmaceuticals LLC |
| 70121-1569 | Releuko Injection, Solution | 300 ug/mL | Amneal Pharmaceuticals LLC |
| 70121-1568 | Releuko Injection, Solution | 300 ug/.5mL | Amneal Pharmaceuticals LLC |
| 61314-318 | Zarxio Injection, Solution | 300 ug/.5mL | Sandoz Inc. |
| 61314-326 | Zarxio Injection, Solution | 480 ug/.8mL | Sandoz Inc. |